Oragenics Inc. Share Price

NASDAQ: OGENHealthcare

$0.47

-0.03 (5.24%)

BUY SELL

Share Price
Performance Overview
Fundamentals
Return Calculator
Company Info
Popular Stocks
FAQ

Live Oragenics Inc. Share Price Chart

O H L

Oragenics Inc. Performance Overview

Days Range

▼

$0.50Low

$0.50High

Markets Today

Previous Close	$0.52
Open	$0.50
Volume	48,946
Day's Range	$0.50 - $0.50
52W Range	$0.48 - $1.45
Market Cap	$2.26 M

Historical Performance

1M Returns	-4.95
3M Returns	-5.53
6M Returns	-34.14
1Y Returns	-57.11
5Y Returns	-99.95
10Y Returns	-99.99

Oragenics Inc. Fundamentals

Market Cap	$2.26 M
Dividend yield	0.00
PE Ratio	0.00
PEG Ratio	N/A
Revenue	$0.00
ROE TTM	-2.44
EPS TTM	$-3.59
Quarterly Earnings Growth YOY	N/A
PB Ratio	0.61
EBITDA	$-9.36 M
Profit Margin	N/A

Market Cap	$2.26 M
Dividend yield	0.00
PE Ratio	0.00
PEG Ratio	N/A
Revenue	$0.00
ROE TTM	-2.44

EPS TTM	$-3.59
Quarterly Earnings Growth YOY	N/A
PB Ratio	0.61
EBITDA	$-9.36 M
Profit Margin	N/A

Oragenics Inc. Profit & Loss

	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue +	$0	$0	$0	$0	$0	$0
Gross Profit +	$0	$0	$0	$0	$0	$0
Operating Income	-$2.03 M	-$1.71 M	-$3.12 M	-$2.50 M	-$2.26 M	-$2.59 M
EBITDA	-$2.03 M	-$1.71 M	-$3.12 M	-$2.50 M	-$2.26 M	-$2.59 M
Interest Expense	-$199.13 K	-$572.31 K	-$7.04 K	-$7.45 K	-$3.73 K	-$414
Depreciation	$0	$0	$0	$0	$0	$0
Income Before Tax	-$2.22 M	-$2.27 M	-$3.07 M	-$2.42 M	-$2.22 M	-$2.58 M
Income Tax Expense	$0	$0	$0	-$136.91 K	-$22.63 K	-$46.38 K
Net Income +	-$2.22 M	-$2.27 M	-$3.07 M	-$2.29 M	-$2.20 M	-$2.53 M
Net Profit Margin	-	-	-	-	-	-

Oragenics Inc. Financials Balance Sheet In USD

	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Share Capital	$21.48 K	$823	$4.13 K	$4.27 K	$4.38 K	$4.51 K
Reserve & Surplus	-$219.00 M	-$221.28 M	-$224.34 M	-$226.63 M	-$228.83 M	-$231.36 M
Non-Current Liabilities	$0	$0	$0	$0	$0	$0
Current Liabilities	$3.73 M	$4.27 M	$2.87 M	$1.79 M	$1.31 M	$1.82 M
Total Liabilities	$3.73 M	$4.27 M	$2.87 M	$1.79 M	$1.31 M	$1.82 M
Fixed Assets	$0	$0	$0	$0	$0	$0
Current Assets	$3.87 M	$2.14 M	$12.71 M	$10.07 M	$7.49 M	$5.49 M
Total Assets	$3.87 M	$2.14 M	$12.71 M	$10.07 M	$7.49 M	$5.49 M

Oragenics Inc. Cash Flow

	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-$2.22 M	-$2.27 M	-$3.07 M	-$2.29 M	-$2.20 M	-$2.53 M
Operating Cash Flow	-$2.11 M	-$1.31 M	-$2.98 M	-$2.84 M	-$2.20 M	-$2.19 M
Investing Cash Flow	$0	$0	$0	$0	$4.00 M	$0
Financing Cash Flow	$4.67 M	-$132.96 K	$12.41 M	-$168.63 K	-$92.00 K	-$56.13 K
Change in Cash	$2.56 M	-$1.45 M	$9.43 M	-$3.00 M	$1.71 M	-$2.24 M

Oragenics Inc. Return Calculator

The Oragenics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT

$10,000

Select Duration

5Yrs

1 Yr5 Yrs

If you had invested $10,000 5 years ago, what would its value be today?$4

Invested Amount$10,000

Est. Returns$-9,996

Invest in USA Stock Today

About Oragenics Inc.

Oragenics Inc is a development-stage biopharmaceutical company dedicated to the research and development of nasal delivery pharmaceutical therapies targeting neurological conditions and infectious diseases. The Company is currently focused on advancing the development and commercialization of its product candidate, ONP-002. ONP-002 is a fully synthetic, non-naturally occurring neurosteroid that is lipophilic and is designed to cross the blood-brain barrier, with the goal of reducing swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The Company's primary focus is on the development and commercialization of ONP-002 for the treatment of mild traumatic brain injury (mTBI), or concussion.

FAQs

What is the share price of Oragenics Inc. today?

Oragenics Inc. (OGEN) share price as of September 18, 2026 is $0.47. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Oragenics Inc.?

Yes, Indian Investors can invest in the Oragenics Inc. (OGEN) Share by opening an international trading account with Angel One.

How can I purchase Oragenics Inc. shares in India?

Purchasing Oragenics Inc. (OGEN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Oragenics Inc. (OGEN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Oragenics Inc.?

Yes, you can purchase fractional shares of Oragenics Inc. (OGEN) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Oragenics Inc.?

The market capitalization of Oragenics Inc. on September 18, 2026, is $2.26 M.

In which sector Oragenics Inc. belongs?

Oragenics Inc. operates in the Healthcare sector, specifically in the Healthcare industry.

What documents are required to invest in Oragenics Inc. stocks?

In order to invest in Oragenics Inc. (OGEN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.